You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV, micro-elimination, DAA

Showing 1 - 25 of 3,960
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Puglia HCV Micro-elimination Program

Completed
  • Hepatitis C
  • Adherence intervention research
  • San Giovanni Rotondo, Fg, Italy
    Alessandra Mangia
Aug 3, 2021

Eliminating HCV Infection Among PWUD

Recruiting
  • Hepatitis C, Chronic
  • Drug Use
  • Vancouver, British Columbia, Canada
    Vancouver Infectious Diseases Centre
Jul 22, 2022

DAA Uptake in Controlling HCV Epidemic and Modeling

Recruiting
  • Hepatitis C
  • +2 more
    • San Diego, California
      Owen Clinic-University of California, San Diego
    Sep 1, 2021

    Hepatitis C Trial in Kaohsiung (Epclusa)

    Active, not recruiting
    • Hepatitis C
    • Kaohsiung, Taiwan
      Kaohsiung Medical University Hospital
    Jul 8, 2020

    Hepatitis B and Hepatitis C (Disorder) Trial in Chongqing (education, no education)

    Completed
    • Hepatitis B and Hepatitis C (Disorder)
    • education
    • no education
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Jan 16, 2021

    HCV Care and Treatment for HIV-HCV Co-infected Decentralised

    Not yet recruiting
    • HIV Infection
    • Hepatitis C Infection
    • Blood samples
    • Vinh, Nghe An, Vietnam
    • +1 more
    Aug 16, 2022

    Surveillance of HCV in Uremics and Linking to Medical Care

    Completed
    • Hepatitis C
    • blood test, noninvasive test for liver fibrosis
    • Kaohsiung, Taiwan
      Kaohsiung Medical University Hospital
    May 26, 2022

    Elimination of Hepatitis C Virus Among Users of Substances

    Not yet recruiting
    • Hepatitis C in Substance Users
    • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
    • (no location specified)
    Aug 14, 2022

    Control and Elimination Within Australia of Hepatitis C From

    Active, not recruiting
    • Hepatitis C
    • +2 more
      • Burwood, New South Wales, Australia
      • +17 more
      Sep 6, 2021

      Strategies for Hepatitis C Testing and Treatment in Aboriginal

      Recruiting
      • Hepatitis C
      • +5 more
      • Fingerstick GeneXpert HCV RNA quantitative assay
      • +2 more
      • Lismore, New South Wales, Australia
      • +3 more
      Apr 13, 2022

      Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,

      Recruiting
      • Hepatitis C
      • +2 more
      • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
      • Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
      • Randwick, New South Wales, Australia
      • +6 more
      Mar 28, 2022

      Hepatitis C, Diagnostic Self Evaluation Trial in Karachi (OraQuick® HCV Self-Test)

      Recruiting
      • Hepatitis C
      • Diagnostic Self Evaluation
      • OraQuick® HCV Self-Test
      • Karachi, Sindh, Pakistan
        Aga Khan University
      Feb 10, 2022

      Hepatitis C Trial in Toronto (HCV care provided by hospitalist during acute psychiatric admission)

      Recruiting
      • Hepatitis C
      • HCV care provided by hospitalist during acute psychiatric admission
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Apr 28, 2022

      The National Australian HCV Point-of-Care Testing Program -

      Not yet recruiting
      • Hepatitis C
      • Point-of-Care Testing
      • (no location specified)
      Feb 9, 2022

      HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

      Completed
      Has Results
      • HCV Coinfection
      • +2 more
      • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
      • Sofosbuvir/Velpatasvir (SOF/VEL)
      • Baltimore, Maryland
        Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
      Feb 10, 2022

      Hepatitis C Trial in San Diego (Simplified HCV care within a mobile medical unit)

      Enrolling by invitation
      • Hepatitis C
      • Simplified HCV care within a mobile medical unit
      • San Diego, California
        Family Health Centers of San Diego
      Mar 14, 2022

      Hepatitis C Trial in Australia (Point-of-Care Testing)

      Recruiting
      • Hepatitis C
      • Point-of-Care Testing
      • Canberra, Australian Capital Territory, Australia
      • +21 more
      Mar 22, 2022

      Ptsd Trial in White River Junction (Glecaprevir / Pibrentasvir Pill)

      Not yet recruiting
      • Ptsd
      • Glecaprevir / Pibrentasvir Pill
      • White River Junction, Vermont
        White River Junction VAMC
      Dec 12, 2022

      Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)

      Not yet recruiting
      • Ptsd
      • White River Junction, Vermont
        White River Junction VAMC
      Dec 12, 2022

      HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

      Not yet recruiting
      • HCV Infection
      • Phnom Penh, Cambodia
        Clinical Trial Unit (Ctu)
      Aug 7, 2023

      Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic Trial in Melbourne (EC clinic support - whole of practice interventions

      Recruiting
      • Hepatitis C
      • +2 more
      • EC clinic support - whole of practice interventions delivery through nurse-led model
      • Melbourne, Victoria, Australia
        Burnet Institute
      Aug 22, 2021

      Hepatitis C Trial (Zinc Supplement)

      Not yet recruiting
      • Hepatitis C
      • Zinc Supplement
      • (no location specified)
      Jul 16, 2022

      HEPATITIS C, Virus, Human Immunodeficiency Trial in Aurora (Directly Observed Therapy, Wirelessly Observed Therapy)

      Completed
      • HEPATITIS C
      • Virus, Human Immunodeficiency
      • Directly Observed Therapy
      • Wirelessly Observed Therapy
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Mar 4, 2022

      End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

      Withdrawn
      • End Stage Renal Disease
      • Chronic Hepatitis c
      • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
      • Boston, Massachusetts
        Massachusetts General Hospital
      Mar 4, 2022

      Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

      Terminated
      • Hepatitis C Virus Infection
      • Sofosbuvir (SOF)
      • +3 more
      • Phoenix, Arizona
      • +50 more
      Jan 25, 2023